BUCK ETF seeks to boost the yield on short-term treasuries through option strategies. The fund uses a combination of treasury bills and options on bond futures. BUCK has underperformed peers like SGOV ...

Q3 2025 Management View Adam Grossman, President and CEO, highlighted "another record quarter of sequential and year-over-year growth, underscoring the strength of our business model and disciplined ...

The competitive landscape of the semiconductor inspection system market is defined by strategic mergers, technological ...

Third Quarter 2025 Financial Results: Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational ...

ADMA Biologics receives FDA approval for a process enhancing plasma production yields by 20%, boosting growth and capacity for its products. ADMA Biologics, Inc. has announced the U.S. FDA approval of ...

TSPY offers ~13% yield, which might not sound too promising in terms of the ETF being included in durable retirement income portfolio. Typically, anything that exceed, say, 8% to 10% yield range ...

--ADMA Biologics, Inc., a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced U.S. FDA approval of its ...

Detection and monitoring of the yield loss mechanisms and defects in product chips have been a subject of extensive efforts, resulting in multiple useful Design-for-Manufacturing (DFM) and ...

HF Sinclair DINO remains a turnaround story. Management is showing progress in improving reliability and efficiency and cutting costs across the portfolio to strengthen competitiveness. It’s focusing ...

Plant biostimulants represent a progressive and sustainable strategy in modern agriculture aimed at enhancing crop yield through improvements in nutrient uptake, growth stimulation and increased ...